Our Pricing

Mounjaro Price Comparison: Which UK Pharmacy Offers Best Value

When conducting a mounjaro price comparison uk pharmacy search, transparent pricing and clinical quality matter equally. At Cured Pharmacy, Mounjaro (tirzepatide) starts from £135.00 with upfront pricing, a free UK prescriber consultation, and genuine MHRA-licensed medication delivered discreetly to your door.

Understanding Mounjaro Pricing in the UK Market

Mounjaro pricing varies significantly across UK online pharmacies, with costs influenced by dose strength, consultation fees, and delivery charges. At Cured Pharmacy, we guarantee the lowest UK prices with full transparency—the £135.00 starting price includes your clinical assessment by a UK-registered prescriber, with no hidden consultation fees added at checkout.

The medication itself contains tirzepatide, a dual GIP/GLP-1 receptor agonist that represents a significant advancement in weight management pharmacotherapy [1]. Understanding what influences pricing helps you identify genuine value rather than simply the lowest headline figure, as some providers add consultation fees or charge separately for prescriber reviews.

All Mounjaro prescriptions in the UK are subject to clinical assessment under MHRA regulations. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription meets the highest safety standards, with our team reviewing your medical history to confirm suitability before dispensing.

How Mounjaro Compares to Other Weight Loss Treatments

Mounjaro differs from earlier GLP-1 treatments through its dual-receptor mechanism, activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously [1]. This dual action produces superior weight reduction outcomes compared to single-pathway alternatives in head-to-head clinical trials.

The SURPASS-2 trial demonstrated that tirzepatide achieved average weight reductions of up to 22.5% over 72 weeks at the 15mg dose, compared to 6.7% with semaglutide 1mg in the same study population [2]. These results positioned Mounjaro as the most effective licensed weight management injection currently available in the UK, subject to prescriber assessment and individual response.

While Wegovy and Saxenda remain effective options for many patients, clinical data consistently shows tirzepatide producing greater average weight loss across dose ranges [1][2]. Your UK prescriber will consider your medical history, previous treatment responses, and individual circumstances when recommending the most appropriate therapy.

Injectable vs Oral Weight Loss Medications

Injectable treatments like Mounjaro work systemically through hormone receptor activation, while oral medications such as Orlistat function locally in the digestive system by blocking fat absorption [3]. Orlistat typically produces more modest weight loss—around 5-10% of body weight when combined with dietary changes—but offers a non-injectable alternative for patients who prefer oral medication.

Mysimba represents another oral option, combining naltrexone and bupropion to reduce appetite through central nervous system pathways [4]. Each treatment class suits different patient profiles, and our UK prescribers assess your preferences alongside clinical factors when recommending therapy.

What Determines the Best Value in Mounjaro Treatment

True value extends beyond the initial price tag. At Cured Pharmacy, our mounjaro price comparison uk pharmacy approach considers total treatment cost, including free prescriber consultations that other providers may charge separately. We also guarantee genuine UK-licensed medication—crucial for safety and efficacy.

Treatment duration typically spans several months as your prescriber gradually increases your dose to optimise results while minimising side effects. The standard titration schedule starts at 2.5mg weekly, increasing every four weeks up to a maintenance dose of 5mg, 10mg, or 15mg depending on your response and tolerability [1]. Planning for this journey means considering ongoing costs, not just the first prescription.

Our transparent pricing model shows exact costs before you complete your consultation, unlike providers who reveal fees only at checkout. This upfront approach, combined with our lowest price guarantee, ensures you receive genuine value throughout your weight management journey.

Hidden Costs to Watch For

Some UK pharmacies advertise low headline prices but add consultation fees, prescription charges, or delivery costs separately. At Cured Pharmacy, our pricing includes your clinical assessment by a UK prescriber—there are no surprise additions when you reach the payment page.

Delivery is discreet and tracked, with medication dispensed only after prescriber approval. Our GPhC-registered pharmacy (9012511) operates under the same regulatory standards as traditional high-street pharmacies, ensuring you receive authentic licensed medication every time.

Clinical Effectiveness: What the Evidence Shows

The SURPASS clinical trial programme evaluated tirzepatide across multiple studies involving thousands of participants. SURPASS-3 specifically compared tirzepatide against insulin degludec in adults with type 2 diabetes, demonstrating average HbA1c reductions of 2.0-2.4% alongside significant weight loss of 7.5-12.9kg depending on dose [5].

For weight management specifically, the SURMOUNT-1 trial enrolled adults with obesity but without diabetes, showing average body weight reductions of 15.0% at the 5mg dose, 19.5% at 10mg, and 20.9% at 15mg over 72 weeks [1]. These results represent averages—individual responses vary based on adherence, lifestyle modifications, and metabolic factors.

NICE guidance acknowledges tirzepatide's superior efficacy profile while noting the importance of comprehensive weight management programmes that include dietary counselling and physical activity alongside pharmacotherapy [6]. Our UK prescribers assess your readiness for treatment and provide guidance on maximising your results through lifestyle modifications.

Safety Profile and Common Side Effects

The most frequently reported side effects in clinical trials were gastrointestinal, including nausea (reported by 20-30% of participants), diarrhoea, and constipation, typically most pronounced during dose escalation phases [1][5]. These effects generally diminish over time as your body adjusts to the medication.

Serious adverse events remain rare but include potential risks of pancreatitis, gallbladder disease, and hypoglycaemia when combined with certain diabetes medications [1]. Your UK prescriber reviews your complete medical history during consultation to identify any contraindications, such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Our clinical team monitors your progress through follow-up assessments, adjusting your dose if side effects become problematic or if you're not achieving expected results. This ongoing prescriber support distinguishes regulated UK pharmacy services from unregulated suppliers operating outside MHRA oversight.

Who Should Not Use Mounjaro

Mounjaro is contraindicated in pregnancy, during breastfeeding, and in patients with a personal or family history of medullary thyroid carcinoma [1]. Individuals with severe gastrointestinal disease, including gastroparesis, should discuss alternative options with their prescriber.

Your online consultation includes detailed questions about your medical history to ensure Mounjaro is clinically appropriate. Our UK prescribers decline approximately 15-20% of applications where safety concerns exist or where alternative treatments would be more suitable—your safety always takes priority over dispensing.

Starting Your Mounjaro Treatment Journey at Cured Pharmacy

Beginning treatment requires completing a free online consultation that takes under three minutes. You'll answer questions about your weight history, current medications, medical conditions, and weight loss goals. A UK-registered prescriber reviews your responses, typically within 24 hours on working days.

If approved, your prescription is sent electronically to our GPhC-registered pharmacy where our team dispenses your medication in discreet, unmarked packaging. Delivery typically occurs within 2-4 working days via tracked courier, with your Mounjaro pens packaged according to cold chain requirements to maintain medication stability.

Your first prescription will be for the 2.5mg starter dose, with follow-up consultations scheduled to increase your dose according to the licensed titration schedule [1]. Our prescribers remain available throughout your treatment for questions, dose adjustments, or if you experience side effects requiring clinical review. This comprehensive care model ensures you receive not just competitive pricing, but complete clinical support throughout your weight management journey.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Bunck, M. C. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-218. https://doi.org/10.1056/NEJMoa2206038
2. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503-515. https://doi.org/10.1056/NEJMoa2107519
3. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161. https://doi.org/10.2337/diacare.27.1.155
4. Greenway, F. L., Fujioka, K., Plodkowski, R. A., Mudaliar, S., Guttadauria, M., Erickson, J., ... & COR-I Study Group. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595-605. https://doi.org/10.1016/S0140-6736(10)60888-4
5. Ludvik, B., Giorgino, F., Jódar, E., Frias, J. P., Fernández Landó, L., Brown, K., ... & SURPASS-3 Investigators. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583-598. https://doi.org/10.1016/S0140-6736(21)01443-4
6. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating type 2 diabetes [TA924]. NICE. https://www.nice.org.uk/guidance/ta924

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary and are subject to prescriber approval and adherence to treatment protocols.